PDX vs ANRISK®

이제부터 치매도 집에서 개인 맞춤형 건강관리를 통해서 예방하고 관리하세요! PDX-AD로 간편하게 자가 설문을 통해 인공지능(AI) 기반 치매 스크리닝 검사를 해보세요. 고위험군은 클릭만으로 방문없이 정밀 분석 신청을 할 수 있습니다. 피디젠 연구소에서 타액을 인공지능(AI)로 분석하여 치매 스크리닝 결과를 앱으로 전송해드립니다. 주요 기능 - 자가 설문을 통한 AI 치매 발병 예측 서비스 무료 제공 - 타액 분석을 통한 AI 치매 발병 및 위험 요인 예측 서비스 ※ 본 애플리케이션은 진단을 예측하는 것으로 치매 진단을 목적으로 하지 않습니다. 정확한 진단을 위해서는 가까운 병원이나 보건소에 방문하시기 바랍니다. ---- 고객센터 : 02-461-3671

"Brain aneurysm, the ticking time bomb in your head: Assess your risk solely based on screening results." Assess Your Brain Aneurysm Risk with ANRISK®—an AI Model Developed by Neurosurgeons. ■ Brain Aneurysms: Early Detection Is Key According to the Brain Aneurysm Foundation, a ruptured brain aneurysm has a fatality rate of 50%, but identifying risk factors early can significantly improve the risk level and prevent irreversible consequences. ■ Quick Analysis Using Basic Health Information ANRISK® is a non-generative AI model developed by a team of neurosurgery experts using 8.8 million person-years worth of data. It analyzes brain aneurysm risk based on 21 key variables such as age, sex, blood pressure, diabetes history, and smoking status. Users can receive a personalized risk score by entering basic health data—no additional tests are required. ■ Personalized Reports for Proactive Health Management Users receive an analysis report with a risk score and are categorized into one of five risk levels. The report also includes personalized health goals and lifestyle guidance to support proactive wellness and long-term risk awareness. ※ This app does not provide medical diagnosis or treatment. All health-related decisions should be made in consultation with a qualified professional. ■ ANRISK® Awards & Recognition *2023 Healthcare Big Data Startup Competition Grand Prize (Minister of Health and Welfare Award) - Rep. of Korea *CHALLENGE! K-Startup 2023 Innovation Startup League (General League) Grand Prize - Rep. of Korea *The 11th Pan Government Data Startup Competition Grand Prize (Presidential Award) - Rep. of Korea *LINA 50+ Awards (Creative Innovation) 1st place - Rep. of Korea ■ Important Disclaimer This app is designed to provide general health-related insights and should not be used for medical purposes. The information and risk scores provided are intended for personal awareness and wellness support only. They are not a substitute for professional medical advice, diagnosis, or treatment, and this app is not classified as a medical device. [Contact] hello@taloscorp.io